[
Federal
Register:
June
2,
2004
(
Volume
69,
Number
106)]
[
Notices]
[
Page
31099­
31100]
From
the
Federal
Register
Online
via
GPO
Access
[
wais.
access.
gpo.
gov]
[
DOCID:
fr02jn04­
47]

­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­

ENVIRONMENTAL
PROTECTION
AGENCY
[
OPPT­
2004­
0084;
FRL­
7361­
4]

Establishment
of
the
Endocrine
Disruptor
Methods
Validation
Advisory
Committee
AGENCY:
Environmental
Protection
Agency
(
EPA).

ACTION:
Establishment
of
Federal
Advisory
Committee
Act
Committee.

­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­

SUMMARY:
As
required
by
section
9(
a)(
2)
of
the
Federal
Advisory
Committee
Act
(
5
U.
S.
C.
App.
2
section
9(
a)(
2)),
we
are
giving
notice
that
EPA
is
establishing
the
Endocrine
Disruptor
Methods
Validation
Advisory
Committee
(
EDMVAC).
The
purpose
of
this
Committee
is
to
provide
a
forum
for
a
diverse
group
of
individuals
representing
a
broad
range
of
interests
and
scientific
expertise.
It
will
provide
advice
to
the
Agency
on
matters
related
to
the
validation
of
assays
under
consideration
by
the
Endocrine
Disruptor
Screening
Program
(
EDSP).
The
Committee
will
analyze
relevant
scientific
issues,
protocols,
review
data
and
interpretations
of
data
for
the
assays.
The
major
objective
of
the
Committee
is
to
provide
advice
and
recommendations
to
the
EPA
Administrator
on
scientific
and
technical
aspects
of
the
assays
as
they
progress
through
the
validation
process.
EPA
has
determined
that
this
advisory
committee
is
in
the
public
interest
and
will
assist
the
Agency
in
performing
its
duties
as
prescribed
by
the
Food
Quality
Protection
Act
of
1996.
Copies
of
the
Committee
Charter
will
be
filed
with
the
appropriate
congressional
committees
and
the
Library
of
Congress.

FOR
FURTHER
INFORMATION
CONTACT:
For
general
information
contact:
Colby
Lintner,
Regulatory
Coordinator,
Environmental
Assistance
Division
(
7404M),
Office
of
Pollution
Prevention
and
Toxics,
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460;
telephone
number:
(
202)
564­
1404;
e­
mail
address:
TSCA­
Hotline@
epa.
gov.
For
technical
information
contact:
Jane
Smith,
Designated
Federal
Official,
Office
of
Science
Coordination
and
Policy
(
7201M),
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460;
telephone
number:
(
202)
564­
8476,
fax:
(
202)
564­
8283;
e­
mail
address:
smith.
jane­
scott@
epa.
gov.

SUPPLEMENTARY
INFORMATION:

I.
Does
this
Action
Apply
to
Me?

This
action
is
directed
to
the
public
in
general.
You
may
be
interested
in
the
establishment
of
the
committee
set
forth
in
this
notice
if
you
are
a
member
of
an
environmental/
public
interest
organization,
a
public
health
organization,
an
animal
welfare
organization,
academia
or
Federal
agencies,
state,
local,
or
tribal
governments.
You
also
may
be
interested
in
activities
of
EPA's
EDSP
if
you
produce,
manufacture,
use,
consume,
work
with,
or
import
pesticides
or
other
chemicals.
Since
other
entities
may
also
be
interested,
the
Agency
has
not
attempted
to
describe
all
the
specific
entities
that
may
be
affected
by
this
action.
If
you
have
any
questions
regarding
this
action,
please
contact
the
technical
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

[[
Page
31100]]

II.
How
Can
I
Get
Additional
Information,
Including
Copies
of
this
Document
or
Other
Related
Documents?

1.
Electronically.
You
may
access
this
Federal
Register
document
electronically
through
the
EPA
Internet
site
under
the
``
Federal
Register''
listings
at
http://
www.
epa.
gov/
fedrgstr/.

Information
about
the
former
Endocrine
Disruptor
Methods
Validation
Subcommittee,
the
Endocrine
Disruptor
Screening
Program
and
related
programs
is
available
from
http://
www.
epa.
gov/
scipoly/
oscpendo/.

EPA
has
established
an
official
public
docket
for
the
EDMVAC
under
docket
identification
(
ID)
number
OPPT­
2004­
0084.
The
official
public
docket
consists
of
the
documents
related
to
the
activities
of
the
committee
and
any
public
comments
received.
Although
a
part
of
the
official
docket,
the
public
docket
does
not
include
Confidential
Business
Information
(
CBI)
or
other
information
whose
disclosure
is
restricted
by
statute.
An
electronic
version
of
the
public
docket
is
available
through
EPA's
electronic
public
docket
and
comment
system,
EPA
Dockets.
You
may
use
EPA
Dockets
at
http://
www.
epa.
gov/
edocket/
to
access
the
index
listing
of
the
contents
of
the
official
public
docket,
and
to
access
those
documents
in
the
public
docket
that
are
available
electronically.
Although
not
all
docket
materials
may
be
available
electronically,
you
may
still
access
any
of
the
publicly
available
docket
materials
through
the
docket
facility
identified
in
Unit
II.
2.
Once
in
the
system,
select
``
search,''
then
key
in
the
appropriate
docket
ID
number.
2.
In
person.
The
official
public
docket
is
the
collection
of
materials
that
is
available
for
public
viewing
at
the
EPA
Docket
Center,
Rm.
B102­
Reading
Room,
EPA
West,
1301
Constitution
Ave.,
NW.,
Washington,
DC.
The
EPA
Docket
Center
is
open
from
8:
30
a.
m.
to
4:
30
p.
m.,
Monday
through
Friday,
excluding
legal
holidays.
The
EPA
Docket
Center
Reading
Room
telephone
number
is
(
202)
566­
1744
and
the
telephone
number
for
the
OPPT
Docket,
which
is
located
in
the
EPA
Docket
Center,
is
(
202)
566­
0272.
3.
By
mail.
You
may
obtain
copies
of
this
document
and
other
related
documents
from
the
technical
contact
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

List
of
Subjects
Environmental
protection,
Endocrine
disruptors,
Endocrine
Disruptor
Screening
Program,
Endocrine
Disrupor
Methods
Validation
Advisory
Committee.

Dated:
May
18,
2004.
Susan
B.
Hazen,
Assistant
Administrator,
Office
of
Prevention,
Pesticides
and
Toxic
Substances.

[
FR
Doc.
04­
12419
Filed
6­
1­
04;
8:
45
am]

BILLING
CODE
6560­
50­
S
